Company Financials

Amicus Therapeutics, Inc. Financials

United States dollar

business Amicus Therapeutics, Inc. Company Profile

Main Stock Listing

NASDAQ: FOLD

Market Capitalization $4.41 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -79.28
Forward PE 22.04
Price to Sales TTM $7.37
Price to Book MRQ $19.10
Enterprise to Revenue 7.65
Enterprise to EBITDA 108.78

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin -2.35%
Operating Margin 20.27%
Return on Assets TTM 2.61%
Return on Equity TTM -6.87%

Income Statement

Revenue TTM $598,704,000
Revenue per Share TTM $1.95
Quarterly Revenue Growth 19.50%
Gross Profit TTM $537,486,016
EBITDA $38,577,000
Net Income to Common TTM $-14,061,000
Diluted EPS TTM $-0.04
Quarterly Earnings Growth YoY 19.46%

Balance Sheet

Total Cash MRQ $263,843,008
Total Cash per Share MRQ $0.86
Total Debt MRQ $
Total Debt to Equity MRQ 192.18
Current Ratio MRQ 2.99
Book Value per Share MRQ $0.75

Cash Flow

Operating Cash Flow TTM $12,976,000
Levered Free Cash Flow TTM $38,403,876

FOLD Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 308,499,614
Float Shares 305,861,647
Avg 10 Volume 28,840,130
Avg 30 Volume None
Shares Short 19,594,481
Short Ratio 3.60
Short % of Shares 6.39%
% Held by Insiders 0.61%
% Held by Institutions 103.63%

Stock Price Summary

Beta 0.46
Fifty Two Week Low $5.51
Fifty Two Week High $14.36
Fifty Two Week Change 34.83%
Day 50 MA $10.40
Day 200 MA $7.88

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date